Versions Compared

Key

  • This line was added.
  • This line was removed.
  • Formatting was changed.

...

Info
titleInformation for Reviewers

Text in black is part of the template used to create this document and is not under review. Please review the blue text; this text represents the changes made to the template that are specific to this QRS instrument.

Please especially note Assumptions 7 thru 9, which discuss the concept of "conditional branching", and Example 1, which shows an example of data not done due to conditional branching in the electronic version of the PRO-CTCAE. Conditional branching replaces the concept of logically skipped items as it allows for situations such as in the electronic version of the PRO-CTCAE where an item is items can be not done due to conditional branching so there is no original result. However, in this case NIH provides scoring for those items not done due to conditional branching. Since it is known that the items were not done due to the symptom not occurring (e.g., when the frequency item response is "never"), any remaining items for the symptom are provided a standardized score of 0.

...

Page properties


Title

Patient-Reported Outcomes Version of the Common Terminology Criteria for Adverse Events (PRO-CTCAE®) Library Version 1.0 (PRO-CTCAE V1.0)

CDISC ReferenceQuestionnaireSupplement to the Study Data Tabulation Model Implementation Guide for Human Clinical Trials
QRS Short Name

PRO-CTCAE V1.0

QRS Permission StatusApproved
TeamPancreatic Cancer Therapeutic Area Team and CDISC Questionnaires, Ratings, and Scales (QRS) Subteam
Supplement Version1.0
StatusDRAFT
Date2022-0405-2101
NotesThis supplement is intended to be used with other CDISC user guides for specific therapeutic/disease areas and follows the CDISC Study Data Tabulation Model Implementation Guide for Human Clinical Trials.


...

Revision History


DateVersion
2022-0405-21011.0 Draft


Info

The CDISC PRO-CTCAE V1.0 supplement version 1.0 was developed based on the NCI/NIH PRO-CTCAE® website. The website’s PRO-CTCAE Version 1.0 Release Notes indicate the revisions made by NCI/NIH on the PRO-CTCAE 1.0 measurement system. The measurement system version is 1.0 based on the website's release notes (specific correction of typographical errors in the different CRF translations). NCI/NIH will notify CDISC of any major changes in the future that would require a change control to the CDISC PRO-CTCAE V1.0 supplement version.

...

  1. As a CDISC QRS standard, the supplement name is PRO-CTCAE V1.0, as provided in this document. As an item library, sponsors may select items from the overall library as a subset of items with the same CDISC Controlled Terminology as appropriate for the condition being studied. It is the users responsibility to identify the subset of items used from the overall PRO-CTCAE V1.0 Item Library (Version 1.0). The subsetted PRO-CTCAE V1.0 user's measurement system should be titled "PRO-CTCAE sponsor-specified symptoms..." based on the sponsor's discretion when they identify the specific items being used. This will distinctly describe the subsetted measurement system from the overall PRO-CTCAE V1.0.
  2. For the PRO-CTCAE V1.0, QSORRES is represented with the text description while the numeric rating is represented in the standardized character and numeric result variables QSSTRESC and QSSTRESN. Please reference the PRO-CTCAE website FAQs for more details on the numeric responsesThe responses for the PRO-CTCAE V1.0 are as follows:

    1. Depending on the symptomatic AE being measured, items assessing symptom presence/absence are rated as follows:
      1. Items assessing symptom presence/absence are rated on a binary response scale and rated from 1-0 (e.g., 1 = “Yes” and 0 = “No”);
      2. Items assessing symptom presence/absence rated on a multiple (more than two) response scale and rated from 1-0 (e.g., 1 = “Yes” and 0 = “No”, and “Not applicable”);
    2. Items assessing symptom frequency are rated on a 5-point scale and are rated from 0-4 (e.g., 0 = “Never”, 1 = “Rarely”, 2 = “Occasionally”, 3 = “Frequently”, and 4 = “Almost constantly”).
    3. Items assessing symptom severity are rated on a 5-point scale rated from 0-4 (e.g., 0 = “None”, 1 = “Mild”, 2 = “Moderate”, 3 = “Severe”, and 4 = “Very severe”).
      1. QSTESTCD=PT01036A assessing symptom severity is rated on a 5-point scale rated from 0-4 (e.g., 0 = “None”, 1 = “Mild”, 2 = “Moderate”, 3 = “Severe”, and 4 = “Very severe”, Not applicable")
    4. Items assessing symptom interference are rated on a 5-point scale and are rated from 0-4 (e.g., 0 = “Not at all”, 1 = “A little bit”, 2 = “Somewhat”, 3 = “Quite a bit”, and 4 = “Very much”).
    5. Items assessing symptom amount are rated on a 5-point scale and rated from 0-4 (e.g., 0 = “Not at all”, 1 = “A little bit”, 2 = “Somewhat”, 3 = “Quite a bit”, and 4 = “Very much”).
    6. QSTESTCD = "PT01066A " to "PT01071A" sexual symptoms have specific responses .
      1. QSTESTCD=PT01069A and QSTESTCD=PT01070A assessing sexual symptom presence/absence are rated on multiple (more than two) response scale and rated from 1-0 (e.g., 1 = “Yes” and 0 = “No”, “Not sexually active”, and “Prefer not to answer”).
      2. QSTESTCD=PT01066A, PT01068A, and PT01071A assessing sexual symptom severity are rated on a 5-point scale rated from 0-4 (e.g., 0 = “None”, 1 = “Mild”, 2 = “Moderate”, 3 = “Severe”, and 4 = “Very severe”, "Not sexually active", and “Prefer not to answer”).

      3. QSTESTCD = "PT01067A" assessing sexual symptom frequency is rated on a 5-point scale rated from 0-4 (e.g., 0 = “Never”, 1 = “Rarely”, 2 = “Occasionally”, 3 = “Frequently”, and 4 = “Almost constantly”, "Not sexually active", and “Prefer not to answer”).
  3. The CRF represents up to 5 "other symptoms" to be recorded. In discussions with NIH, it was agreed to provide up to 10 "other symptoms" to be recorded if they existed. QSTESTCDs (QSTESTCDs "PT01082A" thru "PT01091A") and severity of the symptom at its worst (QSTESTCDs "PT01082B" thru "PT01091B").
  4. PRO-CTCAE V1.0 total scoring instructions have not yet been developed. Item-level scores are not combined (i.e., No total score nor symptom-specific scores are calculated.).
  5. The time period of evaluation for the PRO-CTCAE V1.0 is populated in the QSEVLINT field in ISO 8601 format when the evaluation interval can be precisely described as duration. The evaluation interval for the PRO-CTCAE V1.0 is the past 7 days (QSEVLINT = "-P7D". Please reference the PRO-CTCAE website for more details on the evaluation interval.
  6. Items are divided into 15 subcategories represented in the QSSCAT variable. These categorizations represent how the symptom terms are categorized in the PRO-CTCAE V1.0 Item Library (Version 1.0). See Section 4, SDTM Mapping Strategy, for a list of these subcategory values. 
    1. The symptomatic AE being measured by a given item (e.g., the Symptom Term represented on the CRF corresponding to a given item) is stored in the SUPPQS dataset with the QNAM = "QSSYMPTM". This matches the symptom term identified in the PRO-CTCAE V1.0 Item Library (Version 1.0). The exception to this is the solicited verbatim symptom terms QSTESTCD = "PT01081 to PT01091B"with QNAM = "OTHER SYMPTOMS".
  7. Electronic conditional Conditional branching is recommended by NCI/NIH in the conduct of the electronic version of the PRO-CTCAE V1.0 for symptom terms that have two or more items. The logic branches from frequency, then to severity, then to interference. For example, if frequency is > (greater than) never, you next pose the severity question, and if severity>none, you pose the interference question. Please  Please reference the PRO-CTCAE website for more details on the electronic conditional branching approach.

    1. When a paper version is administered, conditional branching does not apply.
  8. Some items on the PRO-CTCAE may be not done due to electronic conditional branching per the electronic instrument instructions as described in assumption 7. Electronic Electronically branched severity items are assigned responses of 0 = (meaning "None") and electronic electronically branched interference items are assigned 0 = (meaning "Not al all"). When an item is not done due to conditional branching, it is represented as follows:

    1. QSSTAT = "NOT DONE".       

    2. QSREASND = "CONDITIONAL BRANCHING".

    3. QSORRES is set to null (missing).

    4. QSSTRESC = "None" or "Not at all" per the type of item and 0 and QSSTRESN = 0.
  9. Records are created in qs.xpt for every item on the sponsor's version of the instrument. In the conduct of the PRO-CTCAE V1.0 it expects responses for each item and there should be no missing responses. 
    1. For items not done due to conditional branching, refer to assumption 8.
    2. In the unexpected situation where the reason is unknown, then QSORRES, QSSTRESC and QSSTRESN are all missing, QSSTAT = "NOT DONE", and QSREASND is missing.
  10. The language in which the PRO-CTCAE V1.0 was administered (e.g., English, Spanish, Japanese) is collected with the Form Builder application and may be represented as a supplemental qualifier with QNAM = "QSLANGDC". Reference the PRO-CTCAE V1.0 website for a list of available language translations.
  11. Terminology
    1. QSCAT, QSTESTCD, and QSTEST values are included in CDISC Controlled Terminology.

    2. A full list of value sets for the qualifier, and result fields is provided in Section 4, SDTM Mapping Strategy.

...

Dataset wrap
Nameqs


Rowcaps


Rows 20-21:

Represent the electronic conditional branching on data entry for the symptom hiccups did not occur and then the symptom of hiccups severity was assigned 0 = “None”.

Rows 24-26:Represent the electronic conditional branching on data entry for the symptom abdominal pain frequency did not occur. The symptom of abdominal pain severity is assigned 0 = “None” and abdominal pain interference is assigned 0 = “Not at all” for the standardized result values.
Rows 126-129:Represent two additional symptoms that existed for the subject.
Rows 130-145:Represent the symptoms "Other Symptom 3 and Other Symptom 3 Severity" through "Other Symptom 10 and Other Symptom 10 Severity" that did not exist for the subject. These symptoms are represented as "NOT DONE".



Dataset2


RowSTUDYIDDOMAINUSUBJIDQSSEQQSTESTCDQSTESTQSCATQSSCATQSORRESQSSTRESCQSSTRESNQSSTATQSREASNDQSLOBXFLVISITNUMQSDTCQSEVLINT
1STUDYXQS23-P00011PT01001APT01-Dry Mouth SeverityPRO-CTCAE V1.0ORALMild11

Y12015-05-15-P7D
2STUDYXQS23-P00012PT01002APT01-Difficulty Swallowing SeverityPRO-CTCAE V1.0ORALMild11

Y12015-05-15-P7D
3STUDYXQS23-P00013PT01003APT01-Mouth/Throat Sores SeverityPRO-CTCAE V1.0ORALMild11

Y12015-05-15-P7D
4STUDYXQS23-P00014PT01003BPT01-Mouth/Throat Sores InterferencePRO-CTCAE V1.0ORALA little bit11

Y12015-05-15-P7D
5STUDYXQS23-P00015PT01004APT01-Cracking Corners of Mouth SeverityPRO-CTCAE V1.0ORALMild11

Y12015-05-15-P7D
6STUDYXQS23-P00016PT01005APT01-Voice Quality Changes PresencePRO-CTCAE V1.0ORALNo0


Y12015-05-15-P7D
7STUDYXQS23-P00017PT01006APT01-Hoarseness SeverityPRO-CTCAE V1.0ORALMild11

Y12015-05-15-P7D
8STUDYXQS23-P00018PT01007APT01-Taste Changes SeverityPRO-CTCAE V1.0GASTROINTESTINALMild11

Y12015-05-15-P7D
9STUDYXQS23-P00019PT01008APT01-Decreased Appetite SeverityPRO-CTCAE V1.0GASTROINTESTINALMild11

Y12015-05-15-P7D
10STUDYXQS23-P000110PT01008BPT01-Decreased Appetite InterferencePRO-CTCAE V1.0GASTROINTESTINALSomewhat22

Y12015-05-15-P7D
11STUDYXQS23-P000111PT01009APT01-Nausea FrequencyPRO-CTCAE V1.0GASTROINTESTINALOccasionally22

Y12015-05-15-P7D
12STUDYXQS23-P000112PT01009BPT01-Nausea SeverityPRO-CTCAE V1.0GASTROINTESTINALMild11

Y12015-05-15-P7D
13STUDYXQS23-P000113PT01010APT01-Vomiting FrequencyPRO-CTCAE V1.0GASTROINTESTINALOccasionally22

Y12015-05-15-P7D
14STUDYXQS23-P000114PT01010BPT01-Vomiting SeverityPRO-CTCAE V1.0GASTROINTESTINALMild11

Y12015-05-15-P7D
15STUDYXQS23-P000115PT01011APT01-Heartburn FrequencyPRO-CTCAE V1.0GASTROINTESTINALOccasionally22

Y12015-05-15-P7D
16STUDYXQS23-P000116PT01011BPT01-Heartburn SeverityPRO-CTCAE V1.0GASTROINTESTINALMild11

Y12015-05-15-P7D
17STUDYXQS23-P000117PT01012APT01-Gas PresencePRO-CTCAE V1.0GASTROINTESTINALNo00

Y12015-05-15-P7D
18STUDYXQS23-P000118PT01013APT01-Bloating FrequencyPRO-CTCAE V1.0GASTROINTESTINALOccasionally22

Y12015-05-15-P7D
19STUDYXQS23-P000119PT01013BPT01-Bloating SeverityPRO-CTCAE V1.0GASTROINTESTINALMild11

Y12015-05-15-P7D
20STUDYXQS23-P000120PT01014APT01-Hiccups FrequencyPRO-CTCAE V1.0GASTROINTESTINALNever00

Y12015-05-15-P7D
21STUDYXQS23-P000121PT01014BPT01-Hiccups SeverityPRO-CTCAE V1.0GASTROINTESTINAL
None00NOT DONECONDITIONAL BRANCHINGY12015-05-15-P7D
22STUDYXQS23-P000122PT01015APT01-Constipation SeverityPRO-CTCAE V1.0GASTROINTESTINALMild11

Y12015-05-15-P7D
23STUDYXQS23-P000123PT01016APT01-Diarrhea FrequencyPRO-CTCAE V1.0GASTROINTESTINALRarely11

Y12015-05-15-P7D
24STUDYXQS23-P000124PT01017APT01-Abdominal Pain FrequencyPRO-CTCAE V1.0GASTROINTESTINALNever00

Y12015-05-15-P7D
25STUDYXQS23-P000125PT01017BPT01-Abdominal Pain SeverityPRO-CTCAE V1.0GASTROINTESTINAL
None00NOT DONECONDITIONAL BRANCHINGY12015-05-15-P7D
26STUDYXQS23-P000126PT01017CPT01-Abdominal Pain InterferencePRO-CTCAE V1.0GASTROINTESTINAL
Not at all00NOT DONECONDITIONAL BRANCHINGY12015-05-15-P7D
27STUDYXQS23-P000127PT01018APT01-Fecal Incontinence FrequencyPRO-CTCAE V1.0GASTROINTESTINALOccasionally22

Y12015-05-15-P7D
28STUDYXQS23-P000128PT01018BPT01-Fecal Incontinence InterferencePRO-CTCAE V1.0GASTROINTESTINALSomewhat22

Y12015-05-15-P7D
29STUDYXQS23-P000129PT01019APT01-Shortness of Breath SeverityPRO-CTCAE V1.0RESPIRATORYMild11

Y12015-05-15-P7D
30STUDYXQS23-P000130PT01019BPT01-Shortness of Breath InterferencePRO-CTCAE V1.0RESPIRATORYSomewhat22

Y12015-05-15-P7D
31STUDYXQS23-P000131PT01020APT01-Cough SeverityPRO-CTCAE V1.0RESPIRATORYMild11

Y12015-05-15-P7D
32STUDYXQS23-P000132PT01020BPT01-Cough InterferencePRO-CTCAE V1.0RESPIRATORYSomewhat22

Y12015-05-15-P7D
33STUDYXQS23-P000133PT01021APT01-Wheezing SeverityPRO-CTCAE V1.0RESPIRATORYMild11

Y12015-05-15-P7D
34STUDYXQS23-P000134PT01022APT01-Swelling FrequencyPRO-CTCAE V1.0CARDIO/CIRCULATORYOccasionally22

Y12015-05-15-P7D
35STUDYXQS23-P000135PT01022BPT01-Swelling SeverityPRO-CTCAE V1.0CARDIO/CIRCULATORYMild11

Y12015-05-15-P7D
36STUDYXQS23-P000136PT01022CPT01-Swelling InterferencePRO-CTCAE V1.0CARDIO/CIRCULATORYSomewhat22

Y12015-05-15-P7D
37STUDYXQS23-P000137PT01023APT01-Heart Palpitations FrequencyPRO-CTCAE V1.0CARDIO/CIRCULATORYOccasionally22

Y12015-05-15-P7D
38STUDYXQS23-P000138PT01023BPT01-Heart Palpitations SeverityPRO-CTCAE V1.0CARDIO/CIRCULATORYMild11

Y12015-05-15-P7D
39STUDYXQS23-P000139PT01024APT01-Rash PresencePRO-CTCAE V1.0CUTANEOUSNo00

Y12015-05-15-P7D
40STUDYXQS23-P000140PT01025APT01-Skin Dryness SeverityPRO-CTCAE V1.0CUTANEOUSMild11

Y12015-05-15-P7D
41STUDYXQS23-P000141PT01026APT01-Acne SeverityPRO-CTCAE V1.0CUTANEOUSMild11

Y12015-05-15-P7D
42STUDYXQS23-P000142PT01027APT01-Hair Loss AmountPRO-CTCAE V1.0CUTANEOUSQuite a bit33

Y12015-05-15-P7D
43STUDYXQS23-P000143PT01028APT01-Itching SeverityPRO-CTCAE V1.0CUTANEOUSMild11

Y12015-05-15-P7D
44STUDYXQS23-P000144PT01029APT01-Hives PresencePRO-CTCAE V1.0CUTANEOUSNo00

Y12015-05-15-P7D
45STUDYXQS23-P000145PT01030APT01-Hand-Foot Syndrome SeverityPRO-CTCAE V1.0CUTANEOUSMild11

Y12015-05-15-P7D
46STUDYXQS23-P000146PT01031APT01-Nail Loss PresencePRO-CTCAE V1.0CUTANEOUSNo00

Y12015-05-15-P7D
47STUDYXQS23-P000147PT01032APT01-Nail Ridging PresencePRO-CTCAE V1.0CUTANEOUSNo00

Y12015-05-15-P7D
48STUDYXQS23-P000148PT01033APT01-Nail Discoloration PresencePRO-CTCAE V1.0CUTANEOUSNo00

Y12015-05-15-P7D
49STUDYXQS23-P000149PT01034APT01-Sensitivity to Sunlight PresencePRO-CTCAE V1.0CUTANEOUSNo00

Y12015-05-15-P7D
50STUDYXQS23-P000150PT01035APT01-Bed/Pressure Sores PresencePRO-CTCAE V1.0CUTANEOUSNo00

Y12015-05-15-P7D
51STUDYXQS23-P000151PT01036APT01-Radiation Skin Reaction SeverityPRO-CTCAE V1.0CUTANEOUSMild11

Y12015-05-15-P7D
52STUDYXQS23-P000152PT01037APT01-Skin Darkening PresencePRO-CTCAE V1.0CUTANEOUSNo00

Y12015-05-15-P7D
53STUDYXQS23-P000153PT01038APT01-Stretch Marks PresencePRO-CTCAE V1.0CUTANEOUSNo00

Y12015-05-15-P7D
54STUDYXQS23-P000154PT01039APT01-Numbness & Tingling SeverityPRO-CTCAE V1.0NEUROLOGICALMild11

Y12015-05-15-P7D
55STUDYXQS23-P000155PT01039BPT01-Numbness & Tingling InterferencePRO-CTCAE V1.0NEUROLOGICALSomewhat22

Y12015-05-15-P7D
56STUDYXQS23-P000156PT01040APT01-Dizziness SeverityPRO-CTCAE V1.0NEUROLOGICALMild11

Y12015-05-15-P7D
57STUDYXQS23-P000157PT01040BPT01-Dizziness InterferencePRO-CTCAE V1.0NEUROLOGICALSomewhat22

Y12015-05-15-P7D
58STUDYXQS23-P000158PT01041APT01-Blurred Vision SeverityPRO-CTCAE V1.0VISUAL/PERCEPTUALMild11

Y12015-05-15-P7D
59STUDYXQS23-P000159PT01041BPT01-Blurred Vision InterferencePRO-CTCAE V1.0VISUAL/PERCEPTUALSomewhat22

Y12015-05-15-P7D
60STUDYXQS23-P000160PT01042APT01-Flashing Lights in Eyes PresencePRO-CTCAE V1.0VISUAL/PERCEPTUALNo00

Y12015-05-15-P7D
61STUDYXQS23-P000161PT01043APT01-Visual Floaters PresencePRO-CTCAE V1.0VISUAL/PERCEPTUALNo00

Y12015-05-15-P7D
62STUDYXQS23-P000162PT01044APT01-Watery Eyes SeverityPRO-CTCAE V1.0VISUAL/PERCEPTUALMild11

Y12015-05-15-P7D
63STUDYXQS23-P000163PT01044BPT01-Watery Eyes InterferencePRO-CTCAE V1.0VISUAL/PERCEPTUALSomewhat22

Y12015-05-15-P7D
64STUDYXQS23-P000164PT01045APT01-Ringing in Ears SeverityPRO-CTCAE V1.0VISUAL/PERCEPTUALMild11

Y12015-05-15-P7D
65STUDYXQS23-P000165PT01046APT01-Concentration Problems SeverityPRO-CTCAE V1.0ATTENTION/MEMORYMild11

Y12015-05-15-P7D
66STUDYXQS23-P000166PT01046BPT01-Concentration Problems InterferencePRO-CTCAE V1.0ATTENTION/MEMORYSomewhat22

Y12015-05-15-P7D
67STUDYXQS23-P000167PT01047APT01-Memory Problems SeverityPRO-CTCAE V1.0ATTENTION/MEMORYMild11

Y12015-05-15-P7D
68STUDYXQS23-P000168PT01047BPT01-Memory Problems InterferencePRO-CTCAE V1.0ATTENTION/MEMORYSomewhat22

Y12015-05-15-P7D
69STUDYXQS23-P000169PT01048APT01-General Pain FrequencyPRO-CTCAE V1.0PAINOccasionally22

Y12015-05-15-P7D
70STUDYXQS23-P000170PT01048BPT01-General Pain SeverityPRO-CTCAE V1.0PAINMild11

Y12015-05-15-P7D
71STUDYXQS23-P000171PT01048CPT01-General Pain InterferencePRO-CTCAE V1.0PAINSomewhat22

Y12015-05-15-P7D
72STUDYXQS23-P000172PT01049APT01-Headache FrequencyPRO-CTCAE V1.0PAINOccasionally22

Y12015-05-15-P7D
73STUDYXQS23-P000173PT01049BPT01-Headache SeverityPRO-CTCAE V1.0PAINMild11

Y12015-05-15-P7D
74STUDYXQS23-P000174PT01049CPT01-Headache InterferencePRO-CTCAE V1.0PAINSomewhat22

Y12015-05-15-P7D
75STUDYXQS23-P000175PT01050APT01-Muscle Pain FrequencyPRO-CTCAE V1.0PAINOccasionally22

Y12015-05-15-P7D
76STUDYXQS23-P000176PT01050BPT01-Muscle Pain SeverityPRO-CTCAE V1.0PAINMild11

Y12015-05-15-P7D
77STUDYXQS23-P000177PT01050CPT01-Muscle Pain InterferencePRO-CTCAE V1.0PAINSomewhat22

Y12015-05-15-P7D
78STUDYXQS23-P000178PT01051APT01-Joint Pain FrequencyPRO-CTCAE V1.0PAINOccasionally22

Y12015-05-15-P7D
79STUDYXQS23-P000179PT01051BPT01-Joint Pain SeverityPRO-CTCAE V1.0PAINMild11

Y12015-05-15-P7D
80STUDYXQS23-P000180PT01051CPT01-Joint Pain InterferencePRO-CTCAE V1.0PAINSomewhat22

Y12015-05-15-P7D
81STUDYXQS23-P000181PT01052APT01-Insomnia SeverityPRO-CTCAE V1.0SLEEP/WAKEMild11

Y12015-05-15-P7D
82STUDYXQS23-P000182PT01052BPT01-Insomnia InterferencePRO-CTCAE V1.0SLEEP/WAKESomewhat22

Y12015-05-15-P7D
83STUDYXQS23-P000183PT01053APT01-Fatigue SeverityPRO-CTCAE V1.0SLEEP/WAKEMild11

Y12015-05-15-P7D
84STUDYXQS23-P000184PT01053BPT01-Fatigue InterferencePRO-CTCAE V1.0SLEEP/WAKESomewhat22

Y12015-05-15-P7D
85STUDYXQS23-P000185PT01054APT01-Anxious FrequencyPRO-CTCAE V1.0MOODOccasionally22

Y12015-05-15-P7D
86STUDYXQS23-P000186PT01054BPT01-Anxious SeverityPRO-CTCAE V1.0MOODMild11

Y12015-05-15-P7D
87STUDYXQS23-P000187PT01054CPT01-Anxious InterferencePRO-CTCAE V1.0MOODSomewhat22

Y12015-05-15-P7D
88STUDYXQS23-P000188PT01055APT01-Discouraged FrequencyPRO-CTCAE V1.0MOODOccasionally22

Y12015-05-15-P7D
89STUDYXQS23-P000189PT01055BPT01-Discouraged SeverityPRO-CTCAE V1.0MOODMild11

Y12015-05-15-P7D
90STUDYXQS23-P000190PT01055CPT01-Discouraged InterferencePRO-CTCAE V1.0MOODSomewhat22

Y12015-05-15-P7D
91STUDYXQS23-P000191PT01056APT01-Sad FrequencyPRO-CTCAE V1.0MOODOccasionally22

Y12015-05-15-P7D
92STUDYXQS23-P000192PT01056BPT01-Sad SeverityPRO-CTCAE V1.0MOODMild11

Y12015-05-15-P7D
93STUDYXQS23-P000193PT01056CPT01-Sad InterferencePRO-CTCAE V1.0MOODSomewhat22

Y12015-05-15-P7D
94STUDYXQS23-P000194PT01057APT01-Irregular Menstrual Period PresencePRO-CTCAE V1.0GYNECOLOGIC/URINARYNo00

Y12015-05-15-P7D
95STUDYXQS23-P000195PT01058APT01-Missed Menstrual Period PresencePRO-CTCAE V1.0GYNECOLOGIC/URINARYNo00

Y12015-05-15-P7D
96STUDYXQS23-P000196PT01059APT01-Vaginal Discharge AmountPRO-CTCAE V1.0GYNECOLOGIC/URINARYSomewhat22

Y12015-05-15-P7D
97STUDYXQS23-P000197PT01060APT01-Vaginal Dryness SeverityPRO-CTCAE V1.0GYNECOLOGIC/URINARYMild11

Y12015-05-15-P7D
98STUDYXQS23-P000198PT01061APT01-Painful Urination SeverityPRO-CTCAE V1.0GYNECOLOGIC/URINARYMild11

Y12015-05-15-P7D
99STUDYXQS23-P000199PT01062APT01-Urinary Urgency FrequencyPRO-CTCAE V1.0GYNECOLOGIC/URINARYOccasionally22

Y12015-05-15-P7D
100STUDYXQS23-P0001100PT01062BPT01-Urinary Urgency InterferencePRO-CTCAE V1.0GYNECOLOGIC/URINARYSomewhat22

Y12015-05-15-P7D
191STUDYXQS23-P0001191PT01063APT01-Urinary Frequency FrequencyPRO-CTCAE V1.0GYNECOLOGIC/URINARYOccasionally22

Y12015-05-15-P7D
102STUDYXQS23-P0001102PT01063BPT01-Urinary Frequency InterferencePRO-CTCAE V1.0GYNECOLOGIC/URINARYSomewhat22

Y12015-05-15-P7D
103STUDYXQS23-P0001103PT01064APT01-Urine Color Change PresencePRO-CTCAE V1.0GYNECOLOGIC/URINARYNo00

Y12015-05-15-P7D
104STUDYXQS23-P0001104PT01065APT01-Urinary Incontinence FrequencyPRO-CTCAE V1.0GYNECOLOGIC/URINARYOccasionally22

Y12015-05-15-P7D
105STUDYXQS23-P0001105PT01065BPT01-Urinary Incontinence InterferencePRO-CTCAE V1.0GYNECOLOGIC/URINARYSomewhat22

Y12015-05-15-P7D
106STUDYXQS23-P0001106PT01066APT01-Achieve&Maintain Erection SeverityPRO-CTCAE V1.0SEXUALMild11

Y12015-05-15-P7D
107STUDYXQS23-P0001107PT01067APT01-Ejaculation FrequencyPRO-CTCAE V1.0SEXUALOccasionally22

Y12015-05-15-P7D
108STUDYXQS23-P0001108PT01068APT01-Decreased Libido SeverityPRO-CTCAE V1.0SEXUALMild11

Y12015-05-15-P7D
109STUDYXQS23-P0001109PT01069APT01-Delayed Orgasm PresencePRO-CTCAE V1.0SEXUALNo00

Y12015-05-15-P7D
110STUDYXQS23-P0001110PT01070APT01-Unable to Have Orgasm PresencePRO-CTCAE V1.0SEXUALNo00

Y12015-05-15-P7D
111STUDYXQS23-P0001111PT01071APT01-Pain w/Sexual Intercourse SeverityPRO-CTCAE V1.0SEXUALMild11

Y12015-05-15-P7D
112STUDYXQS23-P0001112PT01072APT01-Breast Swelling&Tenderness SeverityPRO-CTCAE V1.0MISCELLANEOUSMild11

Y12015-05-15-P7D
113STUDYXQS23-P0001113PT01073APT01-Bruising PresencePRO-CTCAE V1.0MISCELLANEOUSNo00

Y12015-05-15-P7D
114STUDYXQS23-P0001114PT01074APT01-Chills FrequencyPRO-CTCAE V1.0MISCELLANEOUSOccasionally22

Y12015-05-15-P7D
115STUDYXQS23-P0001115PT01074BPT01-Chills SeverityPRO-CTCAE V1.0MISCELLANEOUSMild11

Y12015-05-15-P7D
116STUDYXQS23-P0001116PT01075APT01-Increased Sweating FrequencyPRO-CTCAE V1.0MISCELLANEOUSOccasionally22

Y12015-05-15-P7D
117STUDYXQS23-P0001117PT01075BPT01-Increased Sweating SeverityPRO-CTCAE V1.0MISCELLANEOUSMild11

Y12015-05-15-P7D
118STUDYXQS23-P0001118PT01076APT01-Decreased Sweating PresencePRO-CTCAE V1.0MISCELLANEOUSNo00

Y12015-05-15-P7D
118STUDYXQS23-P0001118PT01077APT01-Hot Flashes FrequencyPRO-CTCAE V1.0MISCELLANEOUSOccasionally22

Y12015-05-15-P7D
120STUDYXQS23-P0001120PT01077BPT01-Hot Flashes SeverityPRO-CTCAE V1.0MISCELLANEOUSMild11

Y12015-05-15-P7D
121STUDYXQS23-P0001121PT01078APT01-Nosebleed FrequencyPRO-CTCAE V1.0MISCELLANEOUSOccasionally22

Y12015-05-15-P7D
122STUDYXQS23-P0001122PT01078BPT01-Nosebleed SeverityPRO-CTCAE V1.0MISCELLANEOUSMild11

Y12015-05-15-P7D
123STUDYXQS23-P0001123PT01079APT01-Pain&Swelling at Inj Site PresencePRO-CTCAE V1.0MISCELLANEOUSNo00

Y12015-05-15-P7D
124STUDYXQS23-P0001124PT01080APT01-Body Odor SeverityPRO-CTCAE V1.0MISCELLANEOUSMild11

Y12015-05-15-P7D
125STUDYXQS23-P0001125PT01081PT01-Any Other Symptoms ReportedPRO-CTCAE V1.0OTHER SYMPTOMSYes11

Y12015-05-15-P7D
126STUDYXQS23-P0001126PT01082APT01-Other Symptom 1PRO-CTCAE V1.0OTHER SYMPTOMSAnother symptom 1Another symptom 1


Y12015-05-15-P7D
127STUDYXQS23-P0001127PT01082BPT01-Other Symptom 1 SeverityPRO-CTCAE V1.0OTHER SYMPTOMSMild11

Y12015-05-15-P7D
128STUDYXQS23-P0001128PT01083APT01-Other Symptom 2PRO-CTCAE V1.0OTHER SYMPTOMSAnother symptom 2Another symptom 2


Y12015-05-15-P7D
129STUDYXQS23-P0001129PT01083BPT01-Other Symptom 2 SeverityPRO-CTCAE V1.0OTHER SYMPTOMSMild11

Y12015-05-15-P7D
130STUDYXQS23-P0001130PT01084APT01-Other Symptom 3PRO-CTCAE V1.0OTHER SYMPTOMS


NOT DONE
Y12015-05-15-P7D
131STUDYXQS23-P0001131PT01084BPT01-Other Symptom 3 SeverityPRO-CTCAE V1.0OTHER SYMPTOMS


NOT DONE
Y12015-05-15-P7D
132STUDYXQS23-P0001132PT01085APT01-Other Symptom 4PRO-CTCAE V1.0OTHER SYMPTOMS


NOT DONE
Y12015-05-15-P7D
133STUDYXQS23-P0001133PT01085BPT01-Other Symptom 4 SeverityPRO-CTCAE V1.0OTHER SYMPTOMS


NOT DONE
Y12015-05-15-P7D
134STUDYXQS23-P0001134PT01086APT01-Other Symptom 5PRO-CTCAE V1.0OTHER SYMPTOMS


NOT DONE
Y12015-05-15-P7D
135STUDYXQS23-P0001135PT01086BPT01-Other Symptom 5 SeverityPRO-CTCAE V1.0OTHER SYMPTOMS


NOT DONE
Y12015-05-15-P7D
136STUDYXQS23-P0001136PT01087APT01-Other Symptom 6PRO-CTCAE V1.0OTHER SYMPTOMS


NOT DONE
Y12015-05-15-P7D
137STUDYXQS23-P0001137PT01087BPT01-Other Symptom 6 SeverityPRO-CTCAE V1.0OTHER SYMPTOMS


NOT DONE
Y12015-05-15-P7D
138STUDYXQS23-P0001138PT01088APT01-Other Symptom 7PRO-CTCAE V1.0OTHER SYMPTOMS


NOT DONE
Y12015-05-15-P7D
139STUDYXQS23-P0001139PT01088BPT01-Other Symptom 7 SeverityPRO-CTCAE V1.0OTHER SYMPTOMS


NOT DONE
Y12015-05-15-P7D
140STUDYXQS23-P0001140PT01089APT01-Other Symptom 8PRO-CTCAE V1.0OTHER SYMPTOMS


NOT DONE
Y12015-05-15-P7D
141STUDYXQS23-P0001141PT01089BPT01-Other Symptom 8 SeverityPRO-CTCAE V1.0OTHER SYMPTOMS


NOT DONE
Y12015-05-15-P7D
142STUDYXQS23-P0001142PT01090APT01-Other Symptom 9PRO-CTCAE V1.0OTHER SYMPTOMS


NOT DONE
Y12015-05-15-P7D
143STUDYXQS23-P0001143PT01090BPT01-Other Symptom 9 SeverityPRO-CTCAE V1.0OTHER SYMPTOMS


NOT DONE
Y12015-05-15-P7D
144STUDYXQS23-P0001144PT01091APT01-Other Symptom 10PRO-CTCAE V1.0OTHER SYMPTOMS


NOT DONE
Y12015-05-15-P7D
145STUDYXQS23-P0001145PT01091BPT01-Other Symptom 10 SeverityPRO-CTCAE V1.0OTHER SYMPTOMS


NOT DONE
Y12015-05-15-P7D



...